Equity Details
Price & Market Data
Price: $16.84
Daily Change: +$3.29 / 19.54%
Daily Range: $0 - $0
Market Cap: $674,156,160
Daily Volume: 0
Performance Metrics
1 Week: 24.37%
1 Month: 24.37%
3 Months: 45.93%
6 Months: 148.4%
1 Year: 336.3%
YTD: 45.93%
About BrainsWay Ltd. (BRSYF)
A snapshot of BrainsWay Ltd. (BRSYF)'s current market standing: priced at 16.84, with a daily adjustment of +$3.29 / 19.54%. Market cap at 674,156,160. Performance over the last 6 months (148.4%) and YTD are particularly insightful.
Company Details
Employees: 129
Sector: Health technology
Industry: Medical specialties
Country: Israel
Details
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.